{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"study_type":["Transcriptome Analysis"],"full_dataset_link":["https://ega-archive.org/studies/EGAS00001006728"],"host":["EGA"],"description":["EGA study EGAS00001006728"],"dataset_title":["Single cell RNA-sequencing of tissues from NSCLC patients treated with chemoimmunotherapy"],"repository":["EGA"],"category":["restricted"],"name_synonyms":["RNA, Ribonucleic, dTAF[[II]]230, TAF[[II]]250, d230, ribose nucleic acid, non-small cell lung carcinoma, ribonucleic acids, TAF200, l(3)84Ab, dTAFII250, RNS, BG:DS00004.13, non-small cell carcinoma of the lung, TAFII-250, TAF250/230, EfW1, Cell, dTAF230, non-small cell lung cancer, dmTAF[[II]]230, non-small cell cancer of the lung, TAFII250, Client., dmTAF1, Taf230, p230, yeast nucleic acid, Ribonukleinsaeure, Gene Products, TAF[[II]]250/230, TFIID, pentosenucleic acids, Ribonucleic acids, NSCLC - non-small cell lung cancer, Non-small cell lung cancer, non-small cell lung carcinoma (disease), Non Polyadenylated, RNA Gene Products, TAF250, Taf[[II]]250, ribonucleic acid, Acid, Taf200, dTAF[[II]]250, TAF[[II]]230, TFIID TAF250, cel, cell, Non Polyadenylated RNA, Tissue, Non-Polyadenylated, Taf1p, TAF[II]250, Ribonucleic Acid, CG17603, TAF[[II]], Non-Polyadenylated RNA, dTAF250, non-small cell carcinoma of lung, NSCLC, DmelCG17603, Taf250, Patient, SR3-5, Clients, non-small cell cancer of lung, TAF, TAF230, TAF1"],"description_synonyms":["Ribonucleic, d230, Node, Single-Cell RNAseq, Sc RNAseq, non-small cell lung carcinoma, Single Cell Gene Expression Profiling, Neoplasms, Benign Neoplasm, Goal, Non-Small Cell Lung Cancer, dTAFII250, ScRNA seq, Non-Small-Cell Lung, non-small cell carcinoma of the lung, Tumor, EfW1, Malignant, dmTAF[[II]]230, non-small cell cancer of the lung, Lung Carcinomas, single-cell transcriptome sequencing, single-cell RNA-seq, dmTAF1, Taf230, Gene Products, Non-Small-Cell Lung Carcinoma, Seqs, NSCLC - non-small cell lung cancer, Analysis, Non-Small Cell Lung Carcinoma, Non Polyadenylated, RNA Gene Products, Seq, TAF250, Lymph, average, study, Taf200, dTAF[[II]]250, ScRNAseq, TFIID TAF250, Single-Cell Transcriptome Analysis, Analyses, Malignancy, cel, cell, Tissue, Taf1p, Non-Small Cell Lung, Single Cell RNAseq, PMNC, Single Cell RNA Seq, Transcriptome Analysis, RNA Seq, Non Small Cell Lung Carcinoma, Lung Carcinoma, Non-Polyadenylated RNA, ScRNA-seq, Neoplasias, dTAF250, NSCLC, Clients, Nonsmall Cell Lung Cancer, Malignancies, RNA-Seq, TAF, Non-Small-Cell Lung Carcinomas, Cancer, Tumors, Carcinoma, RNA, dTAF[[II]]230, TAF[[II]]250, immune cell, Single-Cell RNA-Seq, Malignant Neoplasm, ribose nucleic acid, lymphatic system, Single-Cell Gene Expression Profiling, ribonucleic acids, TAF200, scRNA-seq, l(3)84Ab, RNS, BG:DS00004.13, PMN cell, TAFII-250, Single Cell Gene Expression Analysis, TAF250/230, Client, Cell, Single-Cell, Single Cell Transcriptome Analysis, dTAF230, non-small cell lung cancer, Sc-RNAseq, TAFII250, single cell RNA sequencing, Benign, p230, yeast nucleic acid, Ribonukleinsaeure, Neoplasm, TAF[[II]]250/230, TFIID, pentosenucleic acids, Ribonucleic acids, Non-small cell lung cancer, non-small cell lung carcinoma (disease), nodus lymphaticus, Carcinomas, Taf[[II]]250, ribonucleic acid, Acid, Single-Cell RNA, Single-Cell Transcriptome Analyses, leucocyte, TAF[[II]]230, Lymph Node, Non Polyadenylated RNA, Non-Polyadenylated, Benign Neoplasms, TAF[II]250, Ribonucleic Acid, Cancers, CG17603, TAF[[II]], Single-Cell RNA Seq, Transcriptome Analyses, sample population, Non Small Cell Lung, Malignant Neoplasms, non-small cell carcinoma of lung, white blood cell, Single-Cell Transcriptome, sample., Lymph node, DmelCG17603, Taf250, Patient, SR3-5, RNAseq, Nodes, lymph gland, non-small cell cancer of lung, other neoplasm, Neoplasia, TAF230, polymorphonuclear cell, TAF1, Non-Small-Cell"],"additional_accession":[]},"is_claimable":false,"name":"Single cell RNA-sequencing of tissues from NSCLC patients treated with chemoimmunotherapy","description":"The goal of this study is to characterize immune cell populations by single cell RNA-sequencing (scRNA-seq) in tumor and uninvolved normal tissues from non-small cell lung cancer (NSCLC) patients with resectable non-small cell lung cancer and who received neoadjuvant chemoimmunotherapy. scRNA-seq was performed on seven pairs of tumor and normal tissues as well as one lymph node (LN) sample.","dates":{"updated":"2023-01-06 10:48:15"},"accession":"EGAS00001006728","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAD00001009778","EGAC00001002967"]}}